Skip to main content

Table 7 SCFA levels differing significantly in patients with active CD, inactive CD, and healthy controls

From: In search for interplay between stool microRNAs, microbiota and short chain fatty acids in Crohn’s disease - a preliminary study

SCFA

Formate

Acetate

Propionate

Butyrate

Isobutyrate

Valerate

CD patients vs. Control

p-value

6.79E-01

2.01E-01

3.59E-01

1.45E-02

4.00E-01

4.78E-03

FC

0.89

1.31

1.20

1.71

1.12

2.51

Active CD vs. Control

p-value

3.06E-01

6.59E-01

8.57E-01

2.15E-01

5.91E-01

1.03E-01

FC

0.79

1.12

0.97

1.34

0.76

1.66

Inactive CD vs. Control

p-value

6.67E-01

6.61E-02

5.47E-02

1.29E-03

2.54E-02

9.67E-05

FC

1.04

1.64

1.65

2.48

2.46

5.96

Active CD vs. Inactive CD

p-value

2.59E-01

1.82E-01

3.90E-02

4.70E-02

2.55E-02

2.55E-02

FC

0.75

0.68

0.59

0.54

0.31

0.28

Control

mean

0.13

2.51

2.13

2.16

1.31

1.47

median

0.12

2.54

2.09

2.16

1.30

1.44

StDev

0.11

0.22

0.21

0.20

0.28

0.24

Inactive

mean

0.10

2.31

1.94

1.79

0.90

0.65

median

0.14

2.33

1.98

1.81

1.04

0.84

StDev

0.16

0.17

0.15

0.15

0.38

0.36

Active

mean

0.21

2.46

2.15

2.02

1.40

1.18

median

0.18

2.51

2.20

2.08

1.50

1.27

StDev

0.19

0.23

0.20

0.24

0.39

0.43